Based on the SURPASS-CVOT trial, tirzepatide becomes the first GIP/GLP-1 drug cleared to lower heart attack, stroke and cardiovascular death risk.
Recap by typeshit. Full story at greatergood.
BuzzFeed notes these medications have helped people worldwide, pro athletes among them, with weight, appetite and blood sugar control.
Novo Nordisk's weight loss drug brand is the presenting sponsor of the playoff game, airing at 4:30 PM ET on TSN, RDS and CFL+.
Novo Nordisk's Wegovy puts its name on the October 31 playoff game in Canada, airing at 4:30 PM ET on TSN, RDS and CFL+.
A doctor writes about a 45-year-old woman without diabetes who came in for obesity treatment, opening a column on how such patients are handled.
The 52-year-old actor points to his early 4am workouts and discipline instead of weight loss shots. A celebrity opinion, not new data.
Metz says the drug improved her mobility enough to handle eight Broadway shows a week in "& Juliet". Her account, not a clinical claim.
Loading…